£39k
−2%vs Jul 2024Active08148167Private limited companyWolverhampton
UK BIOPHARMA LTD
Significant control: Gayane Chobanyan (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for UK Biopharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does UK Biopharma Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
UK BIOPHARMA LTD is an active private limited company (company number 08148167) incorporated on 18 July 2012, registered in Wolverhampton. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 July 2025, showing net assets of £39k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 2% on the prior period (£40k).
Peer position · net assets
By net assets it sits in the upper half of 661 comparable companies in the UK (median £265, upper quartile £89k).
02
Ownership and control
- Dr Gayane Chobanyan
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 July 201214 yrs ago
- Next accounts due
- 30 April 2027in 188 days
- Confirmation statement due
- 1 August 2027in 281 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 86210
- General medical practice activities
- SIC 86900
- Other human health activities
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | £39k | — | — | £42k | — | — | 1 |
| 31 July 2024 | £40k | — | — | £42k | — | — | 1 |
Current ratio0.05Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £39,488 at 31 July 2025
- Current assets below creditors within one yearCurrent ratio 0.05
- Incorporated five or more years agoIncorporated 18 July 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 281 days
- Next accounts duein 188 days
- Accounts period endNet assets £39k · micro accounts
- Accounts period endNet assets £40k · micro accounts
- Incorporated
08
Similar companies in Birmingham
- AAA PHARMACEUTICALS LIMITEDBirmingham · inc. Aug 2012
- FONTUS HEALTH LTDWalsall · inc. May 2012
- NABAWI ACADEMY OF HIJAMA THERAPY LIMITEDBirmingham · inc. Sept 2011
- SYNERGY SPECIALS LIMITEDBirmingham · inc. Jul 2011
- SYNERGY BIOLOGICS LIMITEDWalsall · inc. Aug 2010
- PENTONOVA LIMITEDBirmingham · inc. Jul 2014
All companies incorporated on 18 July 2012 · in Jul 2012.
09
Reminders for UK BIOPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.